info icon

This is a non-core endpoint: only basic statistics are computed.

Lung cancer and mesothelioma

LUNG_CANCER_MESOT

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 C34, C38.4&
Hospital discharge: ICD-9 162|163
Hospital discharge: ICD-8 162|16301
Cause of death: ICD-10 C34, C38.4&
Cause of death: ICD-9 162|163
Cause of death: ICD-8 162|16301
Cancer registry: Topography ICD-O-3 C34|C384
Cancer registry: Morphology ICD-O-3 ANY
Cancer registry: Behaviour codes ANY

3 out of 7 registries used, show all original rules.

7844

diagram downward connector

Check minimum number of events None

7844

diagram downward connector

Include endpoints None

7844

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

7600

diagram downward connector
LUNG_CANCER_MESOT

Control definitions

Control exclude ASTHMA_EXCL

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

List of similar endpoints to Lung cancer and mesothelioma based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 7600 1880 5720
Unadjusted prevalence (%) 2.02 0.89 3.44
Mean age at first event (years) 70.76 67.46 71.85

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: LUNG_CANCER_MESOT – Lung cancer and mesothelioma
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Lung cancer and mesothelioma

Endpoint not on priority list, no data to show.